{"id":7795,"date":"2026-02-24T06:08:26","date_gmt":"2026-02-24T06:08:26","guid":{"rendered":"https:\/\/pandapeptides.com\/research\/cjc-1295-ipamorelin\/"},"modified":"2026-04-29T09:09:00","modified_gmt":"2026-04-29T16:09:00","slug":"cjc-1295-ipamorelin","status":"publish","type":"page","link":"https:\/\/pandapeptides.com\/es\/research\/cjc-1295-ipamorelin\/","title":{"rendered":"CJC-1295 + Ipamorelin \u2014 Published Research"},"content":{"rendered":"<div style=\"max-width:800px;margin:0 auto\">\n<p style=\"color:#a1a1aa;font-size:14px;margin-bottom:30px\"><a href=\"\/es\/producto\/cjc-1295-ipamorelin\/\" style=\"color:#00e5ff\">\u2190 Back to CJC-1295 + Ipamorelin product page<\/a><\/p>\n<section id=\"panda-cjc-ipa-research-orientation\" style=\"background:#111827;border-radius:14px;padding:20px 22px;margin:28px 0\">\n<h2 style=\"color:#fafafa;margin:0 0 10px;font-size:24px\">How to read this CJC-1295 + Ipamorelin research page<\/h2>\n<p style=\"color:#a1a1aa;line-height:1.7;margin:0 0 12px\">This page summarizes published literature for the component pathways commonly reviewed together in catalog contexts: modified GRF\/GHRH analog signaling and Ipamorelin ghrelin-receptor signaling. It is structured for literature orientation and documentation review only.<\/p>\n<ul style=\"color:#a1a1aa;line-height:1.7;margin:0 0 12px 20px\">\n<li><strong style=\"color:#fafafa\">Component framing:<\/strong> citations are grouped by receptor-system context rather than by protocol or intended use.<\/li>\n<li><strong style=\"color:#fafafa\">Research framing:<\/strong> summaries describe receptor assays and experimental models; they do not establish product claims or therapeutic outcomes.<\/li>\n<li><strong style=\"color:#fafafa\">Documentation links:<\/strong> compare the <a href=\"\/es\/producto\/cjc-1295-ipamorelin\/\" style=\"color:#00e5ff\">blend listing<\/a>, <a href=\"\/es\/coa\/\" style=\"color:#00e5ff\">COA hub<\/a>, y <a href=\"\/es\/research-framework\/\" style=\"color:#00e5ff\">research framework<\/a>.<\/li>\n<\/ul>\n<p style=\"color:#71717a;font-size:13px;line-height:1.6;margin:0\">Panda Peptides products are for research use only. No dosing, administration, reconstitution, treatment, hormone-use, or human-use guidance is provided.<\/p>\n<\/section>\n<div style=\"margin-top:40px;max-width:900px\">\n<h3 style=\"color:#fafafa;font-size:22px;margin-bottom:8px\">Biblioteca de investigaci\u00f3n<\/h3>\n<p style=\"color:#71717a;font-size:13px;margin-bottom:20px\">Published research on these compounds \u2014 for educational purposes only<\/p>\n<details style=\"background:#18181b;border-radius:10px;margin-bottom:12px;overflow:hidden\">\n<summary style=\"padding:18px 24px;color:#00e5ff;font-size:16px;font-weight:600;cursor:pointer\">Dual receptor signaling<\/summary>\n<div style=\"padding:0 24px 20px;color:#a1a1aa;font-size:15px;line-height:1.7\">\n<p>This combination has been studied in receptor-signaling models using coordinated peptide agonism. One component activates a class B GPCR pathway through cAMP\/PKA signaling, while ipamorelin activates GHS-R1a through phospholipase C\/IP3\/calcium pathways. Co-stimulation of both receptor systems in pituitary models produced additive signaling output in published rat studies.<\/p>\n<p style=\"font-size:12px;color:#52525b;font-style:italic\">Bowers CY et al. &#8220;On the activity of a new synthetic hexapeptide in pituitary signaling models.&#8221; <em>Endocrinology.<\/em> 1984. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/6432688\/\" style=\"color:#71717a\" rel=\"nofollow noopener\" target=\"_blank\">PubMed<\/a><\/p>\n<\/div>\n<\/details>\n<details style=\"background:#18181b;border-radius:10px;margin-bottom:12px;overflow:hidden\">\n<summary style=\"padding:18px 24px;color:#00e5ff;font-size:16px;font-weight:600;cursor:pointer\">Ipamorelin Selectivity Profile<\/summary>\n<div style=\"padding:0 24px 20px;color:#a1a1aa;font-size:15px;line-height:1.7\">\n<p>Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH\u2082) is a pentapeptide characterized by selective GHS-R1a activity in pituitary models. In swine pituitary cell culture models, ipamorelin stimulated GH release with an EC\u2085\u2080 of approximately 1.3 nM without significant effects on ACTH, cortisol, prolactin, or FSH\/LH release at effective concentrations. This selectivity profile distinguishes it from earlier GHS compounds like GHRP-6 and hexarelin, which show broader hormonal stimulation.<\/p>\n<p style=\"font-size:12px;color:#52525b;font-style:italic\">Raun K et al. &#8220;Ipamorelin, a selective peptide agonist in pituitary models.&#8221; <em>Eur J Endocrinol.<\/em> 1998. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9849822\/\" style=\"color:#71717a\" rel=\"nofollow noopener\" target=\"_blank\">PubMed<\/a><\/p>\n<\/div>\n<\/details>\n<details style=\"background:#18181b;border-radius:10px;margin-bottom:12px;overflow:hidden\">\n<summary style=\"padding:18px 24px;color:#00e5ff;font-size:16px;font-weight:600;cursor:pointer\">CJC-1295 (Mod GRF 1-29) Structure and Pharmacokinetics<\/summary>\n<div style=\"padding:0 24px 20px;color:#a1a1aa;font-size:15px;line-height:1.7\">\n<p>CJC-1295 without DAC (also known as Modified GRF 1-29) is a tetra-substituted analog of GRF(1-29) with modifications at positions 2 (D-Ala), 8 (Gln), 15 (Ala), and 27 (Leu). These substitutions confer resistance to DPP-IV and other proteolytic enzymes, extending the biological half-life from the approximately 7-minute native peptide half-life to roughly 30 minutes. The peptide retains full agonist activity at the target receptor with equivalent binding affinity to native GRF(1-29).<\/p>\n<p style=\"font-size:12px;color:#52525b;font-style:italic\">Ionescu M, Frohman LA. &#8220;Pulsatile GH-axis signaling persists during continuous stimulation by CJC-1295, a long-acting GRF analog.&#8221; <em>J Clin Endocrinol Metab.<\/em> 2006. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17018654\/\" style=\"color:#71717a\" rel=\"nofollow noopener\" target=\"_blank\">PubMed<\/a><\/p>\n<\/div>\n<\/details>\n<\/div>\n<div class=\"panda-research-next-card\" style=\"margin:28px 0 0;padding:20px;background:#111113;border:1px solid #27272a;border-radius:14px;color:#a1a1aa;font-size:14px;line-height:1.65\">\n<h3 style=\"margin:0 0 10px;color:#fafafa;font-size:18px;line-height:1.3\">Continue reviewing CJC-1295 + Ipamorelin<\/h3>\n<p style=\"margin:0 0 14px\">Use the research references above alongside Panda\u2019s batch documentation and catalog specifications.<\/p>\n<div style=\"display:flex;flex-wrap:wrap;gap:10px\"><a href=\"\/es\/producto\/cjc-1295-ipamorelin\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#00e5ff;text-decoration:none;border:1px solid #27272a\">View product specs<\/a><a href=\"\/es\/coa\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#00e5ff;text-decoration:none;border:1px solid #27272a\">Check COA library<\/a><a href=\"\/es\/quality-and-testing\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#d946ef;text-decoration:none;border:1px solid #27272a\">Quality &amp; testing<\/a><a href=\"\/es\/research-framework\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#00e5ff;text-decoration:none;border:1px solid #27272a\">Evaluation guide<\/a><a href=\"\/es\/research\/\" style=\"display:inline-block;padding:9px 12px;border-radius:999px;background:#18181b;color:#a1a1aa;text-decoration:none;border:1px solid #27272a\">Research library<\/a><\/div>\n<\/div>\n<div style=\"margin-top:30px;padding:20px;background:#18181b;border-radius:10px;color:#71717a;font-size:13px\">\n<p><strong>Disclaimer:<\/strong> All research citations are provided as references to published laboratory literature only. These materials may summarize in vitro and animal-model findings. Products are sold strictly for laboratory research use only. This page is provided for research-reference and documentation review only.<\/p>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u2190 Back to CJC-1295 + Ipamorelin product page How to read this CJC-1295 + Ipamorelin research page This page summarizes published literature for the component pathways commonly reviewed together in catalog contexts: modified GRF\/GHRH analog signaling and Ipamorelin ghrelin-receptor signaling. It is structured for literature orientation and documentation review only. Component framing: citations are grouped [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":7787,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-7795","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7795","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/comments?post=7795"}],"version-history":[{"count":5,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7795\/revisions"}],"predecessor-version":[{"id":9502,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7795\/revisions\/9502"}],"up":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7787"}],"wp:attachment":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/media?parent=7795"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}